A review of existing and emerging digital technologies to combat the global trade in fake medicines
Authors:
Top Cited Papers
- 7 April 2017
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 16 (5) , 587-602
Abstract
Introduction: The globalization of the pharmaceutical supply chain has introduced new challenges, chief among them, fighting the international criminal trade in fake medicines. As the manufacture, supply, and distribution of drugs becomes more complex, so does the need for innovative technology-based solutions to protect patients globally. Areas covered: We conducted a multidisciplinary review of the science/health, information technology, computer science, and general academic literature with the aim of identifying cutting-edge existing and emerging ‘digital’ solutions to combat fake medicines. Our review identified five distinct categories of technology including mobile, radio frequency identification, advanced computational methods, online verification, and blockchain technology. Expert opinion: Digital fake medicine solutions are unifying platforms that integrate different types of anti-counterfeiting technologies as complementary solutions, improve information sharing and data collection, and are designed to overcome existing barriers of adoption and implementation. Investment in this next generation technology is essential to ensure the future security and integrity of the global drug supply chain.Keywords
This publication has 98 references indexed in Scilit:
- Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanismBMC Medicine, 2013
- Evaluating Aspects of Online Medication Safety in Long-Term Follow-Up of 136 Internet Pharmacies: Illegal Rogue Online Pharmacies Flourish and Are Long-LivedJournal of Medical Internet Research, 2013
- Big Data Opportunities for Global Infectious Disease SurveillancePLOS Medicine, 2013
- Anti-Counterfeit Technologies: A Pharmaceutical Industry PerspectiveScientia Pharmaceutica, 2013
- An examination of pharmaceutical systems in severely disrupted countriesBMC International Health and Human Rights, 2012
- Combating healthcare corruption and fraud with improved global health governanceBMC International Health and Human Rights, 2012
- Digital EpidemiologyPLOS Computational Biology, 2012
- Poor quality vital anti-malarials in Africa - an urgent neglected public health priorityMalaria Journal, 2011
- Dangerous medicines: Unproven AIDS cures and counterfeit antiretroviral drugsGlobalization and Health, 2008
- Bitter pillsBMJ, 2007